Molecular Mediators of Cardiac Pathology in Cardiorenal Syndrome Type 4 [mRNA]
收藏Alliance of Genome Resources2026-08-01 收录
官方服务：
资源简介：
We report the changes in left ventricle mRNA abundance in response to 5/6 nephrectomy surgery
应用场景：
相关数据集
Empagliflozin reduces left ventricular mass increase and improves cardiomyocyte hypertrophy after 5/6 nephrectomy.
Methods and Results : Using a 5/6 nephrectomy rat model to induce cardiorenal syndrome, we administered two doses of Empagliflozin (3 mg/kg/day and 15 mg/kg/day) via gavage for 95 days, w
DataCite Commons2025-04-08 更新70
Supplementary Material for: Initiation and Cessation Timing of Renal Replacement Therapy in Patients with Type 1 Cardiorenal Syndrome: An Observational Study
Background/Aims: Renal replacement therapy (RRT) is a rescue therapy for patients with type 1 cardiorenal syndrome (CRS) with poor prognoses. However, the optimal timing for initiation a
DataCite Commons2020-09-02 更新50
Effect of two weeks erythropoietin treatment on monocyte transcriptomes of cardiorenal patients
Patients with combined heart and renal failure, also termed the cardiorenal syndrome (CRS), have high cardiovascular morbidity and mortality. Several key connectors between heart and kidney have been
NIAID Data Ecosystem30
Acute Cardiorenal Syndrome: Which Diagnostic Criterion to Use And What is its Importance for Prognosis?
Abstract The absence of a consensus about the diagnostic criteria for acute cardiorenal syndrome (ACRS) affects its prognosis. This study aimed at assessing the diagnostic criteria for ACRS and their
DataCite Commons2021-03-25 更新60
Supplementary Material for: Initiation and Cessation Timing of Renal Replacement Therapy in Patients with Type 1 Cardiorenal Syndrome: An Observational Study
Background/Aims: Renal replacement therapy (RRT) is a rescue therapy for patients with type 1 cardiorenal syndrome (CRS) with poor prognoses. However, the optimal timing for initiation a
DataCite Commons2020-09-02 更新50
